Zheshang Securities is bullish on the market prospects of in...

Zheshang Securities is bullish on the market prospects of innovative drugs and medical devices in the medical and health industry, and optimistic about the growth of pharmaceutical demand. The report explicitly states the risks involved in investing in the medical and health industry, including policy change risks, risks of new drug research and development failures, and the uncertainty of sales reform effects.